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Available online 10 May 2011Abstract A muscle progenitor cell population, other than muscle satellite cells, can be isolated and purified from porcine
muscle tissue. We show the presence of at least two types of stem cells in porcine muscle: those that express α6 integrin and
those that lack expression of this integrin type. By flow cytometry, we could select for myogenic stem cell populations
expressing the neural cell adhesion molecule in the presence and absence of α6 integrin. The expression of α6 integrin showed
an advantage in the formation of myotubes, possibly by an improved cell fusion capacity. This notion was strengthened by qRT-
PCR analysis showing sustained PAX7, MYF5 and DESMIN expression and a strong myogenic differentiation capacity of this stem
cell population. Selective inhibition of α6 integrin function, both by blocking antibodies and RNA interference, showed the
importance of α6 integrin in myogenic differentiation of muscle stem cells. It is concluded that α6 integrin expression can be
used as biomarker to select for highly myogenic cell populations in muscle tissue.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
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of muscle fibers and possess a self-renewing capacity to
sustain the resident stem cell pool (Montarras et al., 2005).
The characteristic PAX7 expression by satellite cells is
important to maintain postnatal self-renewal and myogenic
commitment until activation upon damage or during devel-
opment occurs (Seale et al., 2000; McKinnell et al., 2008;
Relaix et al., 2005; Oustanina et al., 2004). Here, cells start
to proliferate and differentiate into myoblasts, a process
coordinated by the muscle regulatory factors (MRFs) Myf5 and
MyoD (Buckingham et al., 2003; Rudnicki et al., 1993;
Tajbakhsh, 2005). The second differentiation step occurs
after myoblast alignment, initiating myoblast fusion resulting
in the formation of myotubes. The MRF Myogenin controls.
113Alpha 6 integrin is important for myogenic stem cell differentiationterminal differentiation into maturemyofibers (Pownall et al.,
2002; Alapat et al., 2009).
Integrins function as receptors important for adhesion to
extracellular matrix (ECM) proteins or to other cells. They
are composed of α- (18 types) and β- (8 types) subunits that
can form 24 distinct heterodimers of which the composition
dictates ligand specificity (Hemler, 1999; Hynes, 2002; van
der Flier and Sonnenberg, 2001). In particular the integrin
β1 has a role in regulating muscle integrity and is essential
for myoblast adhesion to the ECM (Menko and Boettiger,
1987). During muscle development various integrin subunits
are expressed including α1, α4, α5, α6, α7, αV, β1 and β3.
They play roles in mediating modulation of cell proliferation,
differentiation, migration, polarity, and motility triggering
calcium influx and are involved in apoptosis (Hynes, 2002;
Danen and Sonnenberg, 2003; Gullberg et al., 1998). The
integrinα7β1 is expressedonmyoblasts localized in and around
the myotendinous and neuromuscular junction of the muscle
fiber and is required for muscle maintenance (Bao et al., 1993;
Hayashi et al., 1998). In a study with quail embryonic muscle,
α5 integrin in myoblasts was demonstrated to stimulate
proliferation, whereas α6 integrin mediated differentia-
tion (Sastry et al., 1996). This suggests distinct functions
for α-integrins in regulating myogenesis from proliferation
towards terminal differentiation.
Functions of α6 integrin (α6ITG) have been studied using
a GoH3 neutralizing antibody directed against α6ITG. It is
suggested that α6β1 is involved in adhesion to the E8-cell-
binding site of laminin in non-muscle cells, whereas in
muscle cells, not α6β1, but a different β1 integrin-series
binds laminin (von der Mark et al., 1991; Sonnenberg et al.,
1990). Alpha 6 integrin is expressed during early
mouse development at the stages of laminin containing
basement formation, which remains during embryogenesis
(Hierck et al., 1993). Here, delamination of Myf5 expres-
sing muscle progenitor cells formed laminin-rich myotome
mediated by α6β1 integrin expression (Bajanca et al.,
2004, 2006). Previous results showed that sustained α6ITG
expression of muscle stem cells cultured on Matrigel
surface coating was correlated with a high myogenic
differentiation in vitro, suggesting a role for α6ITG during
muscle stem cell differentiation (Wilschut et al., 2010).
Muscle tissue contains a heterogeneous population of
muscle progenitor cells (Zammit et al., 2006; Kuang et al.,
2007; Cerletti et al., 2008). Selection for specific
progenitor cells can be important to enrich for homoge-
neous cell populations to study function and differentia-
tion potentials. Indeed, in several studies integrins as
well as other membrane associated biomarkers were
used to select for specific stem cell populations (Cerletti
et al., 2008; Webster et al., 1988; Sherwood et al., 2004;
Tamaki et al., 2002; Zheng et al., 2007). In this respect,
expression of the neuronal cell adhesion molecule (NCAM)
by satellite cells has been used to mark a myogenic cell
population (Capkovic et al., 2008; Mesires and Doumit,
2002).
In this study, muscle stem cells isolated from the pig
were used. We used flow cytometry to sort for muscle stem
cells based on biomarker expression of NCAM and α6ITG.
These cells were examined for their myogenic differentia-
tion capacity revealing a potential function of α6ITG during
myogenesis.2. Results
2.1. Muscle tissue contains satellite cells with distinct
α6ITG expression levels
To specifically localize cells expressing α6ITG and to detect
muscle satellite cells by PAX7 expression, cryosections of
porcine semitendinosus muscle were stained with antibodies
against PAX7, α6ITG and Laminin. Two types of satellite cells
could be distinguished; (1) PAX7-expressing (satellite) cells
that lacked α6ITG expression (Fig. 1D; arrowhead) and (2)
PAX7-expressing cells (satellite) that co-expressed α6ITG
(Fig. 1D; arrow). Additionally, α6ITG expressing cells that
lacked PAX7 expression were observed (Fig. 1D; asterisks).
Thus, the identification of at least two different satellite cell
types indicates the heterogeneity of satellite cells in muscle.
Furthermore, α6ITG expressing cells were observed adjacent
to the extracellular matrix component laminin, indicating
the presence of these cells in laminin rich muscle areas
(Fig. 1E-H).2.2. Selection forα6ITG expression results in highly
myogenic committed stem cell population
Isolated porcine primary muscle stem cells were expanded
on Matrigel-coated flasks. Myogenic stem cell populations
were selected by flow cytometry based on antibodies
directed against NCAM (expressed by satellite cells) and
α6ITG. The FITC- and PE-conjugated isotype control anti-
bodies were used to gate the background. Three cell
populations were sorted individually (Fig. 2); (1) NCAM+/
α6ITG+ population (22%), (2) NCAM+/ α6ITG− cells (8%) and
(3) NCAM-/ α6ITG− cells (3%) (double negative for α6ITG and
NCAM), most likely representing non-myogenic cells.
All other experiments were conducted using laminin- and
Matrigel-coated plates functioning as substrates containing
α6ITG engaging ligands (Sonnenberg et al., 1990). The
myogenic differentiation capacity of the sorted NCAM+/
α6ITG+ cell population was demonstrated by detection of
myogenic related protein expression. Detection of MYOGENIN,
DESMIN and MYHC expression (Fig. 3A) revealed the high
myogenic character of this cell population and was also
indicated by formation of (striated) myotubes after 4 days of
differentiation (Fig. 3A, arrow andarrowhead). The expression
of α6ITG confirmed cell sorting efficiency. Cells expressing
α6ITG formed large multinucleated myotubes while cells
lacking α6ITG expression only displayed alignment of the cells
without fusion (Fig. 3B). Myotube formation was never
observed in NCAM+ cells lacking α6ITG expression (data not
shown).Gene expressionwas quantified by qRT-PCR andmRNA
levels were determined relative to those of unsorted primary
muscle cells. The NCAM+/ α6ITG+ population showed a
significantly (pb0.001) higher expression of A6ITG mRNA
compared to the expression of the NCAM+/ α6ITG− sorted
population demonstrating successful separation of the popula-
tions (Fig. 3C). Interestingly, the NCAM+/ α6ITG− population
expressed significantly higher levels of A7ITGmRNA, whereas,
the NCAM−/ α6ITG− population, expressed significantly
(pb0.001) higher levels of A5ITG mRNA. The B1ITG mRNA
levels were similar between the two NCAM+ populations.
Cell type # Percentage 
α6ITG+ cells 140 41% 
PAX7+ cells 41 12% 
α6ITG+/ PAX7+ 24 7% 
α6ITG-/ PAX7+ 18 5% 





Figure 1 Immunofluorescence of PAX7 and α6ITG expression in transverse cryosections of semitendinosus muscle tissue.
A. Localization of α6ITG expression with anti-α6ITG antibodies (GoH3, red). B. Satellite cells are identified by PAX7 expression using
anti-PAX7 antibodies (PAX7, green). C, G. Visualization of nuclei by DAPI (blue). D. Merged channels showing three different cell
populations; α6ITG expressing satellite cells (arrows), satellite cells lacking α6ITG expression (arrowheads) and unidentified muscle
cells with α6ITG expression (asterisks). Scale bars represent 20 μm. E. Localization of α6ITG expression with anti-α6ITG antibodies
(GoH3, green). F. Visualization of the extracellular matrix component laminin (red). H. Merged channels identifying the sub-laminar
position of α6ITG positive cells. I. Determination of frequency of different cell types. Scale bars represent 50 μm.
114 K.J. Wilschut et al.Examination of muscle related gene expression revealed
that both NCAM+ populations comprised a high PAX7
expression with a significantly (pb0.05) higher MYF5
expression in α6ITG+ cells (Fig. 3C). MYF5 is important for
initiation of muscle differentiation, suggesting a stronger
myogenic potential of the α6ITG+ cells. However, DESMINFigure 2 Flow cytometric analysis of primary muscle stem cells
populations corresponding to specific antibody staining as indicated
cells were visualized in FITC-channel. The NCAM+/ α6ITG+ population
of the total population. B. Negative isotype control represents non-expression was significantly (pb0.05) higher in α6ITG− cells,
indicating a strong myogenic feature despite the lower MYF5
expression. The NCAM-/ α6ITG− cell population showed lower
expression levels of MYF5 and DESMIN, which are important
during myogenesis, demonstrating the non-myogenic feature
of these cells. Morphology of both NCAM+ populations showedfor NCAM and α6ITG expression. A. Gates represent sorted cell
. NCAM+ cells were visualized by the PE-channel and the α6ITG+
represented 22%, NCAM+/ α6ITG− cells 8% and NCAM-/ α6ITG− 3%
specific background staining.
115Alpha 6 integrin is important for myogenic stem cell differentiationbi- and triangular shaped cells with several pseudopodia.
However,α6ITG+ cells exhibiting amore flattenedmorphology
compared to the α6ITG- cells (Fig. 4A).
The difference between the two populations (NCAM+/
α6ITG+/−) concerning their growth rate was monitored by
the determination of cell numbers. Cells lacking α6ITG
expression had a 3-fold higher expansion rate compared to
α6ITG+ cells as indicated at day 7 of proliferation (Fig. 4B).
In differentiation medium, NCAM+/ α6ITG− cells sustained a
high proliferative activity suggesting no initiation of
differentiation.
2.3. Alpha 6 integrin is required for robust myogenic
differentiation
To examine and compare the myogenic differentiation
capacity of the NCAM+/ α6ITG+/− cell populations the
expression of genes involved in myogenesis was measured by
qRT-PCR during differentiation. Here, both NCAM+/ α6ITG+
and NCAM+/ α6ITG−populations showed approximately equal
PAX7 mRNA levels directly after sorting. Initiation of differen-
tiation resulted in a drop of PAX7 expression in both
populations, whereas PAX7 expression recovered in α6ITG+
cells significantly towards α6ITG− cells during differentiation
(Fig. 5A). Levels of MYF5mRNA, coding for the transcriptional
initiator of muscle stem cell differentiation, remained
significantly higher (pb0.01) in α6ITG+ cells compared to
α6ITG− cells after sorting. This indicates the low myogenic
orientation of these cells when lacking α6ITG expression
(Fig. 5B). In the α6ITG− cells a decrease in DESMIN expression
was observed (Fig. 5C). The expression of intermediated
muscle filament protein DESMIN sustained in α6ITG+ cells
(pb0.001), while DESMIN in α6ITG− cells reduced considerably
after several days of differentiation. Furthermore, the
morphological myotube formation by α6ITG+ cells was corre-
lated to the remarkable increase of MYHC expression (compo-
nent of the fast typemuscle fiber compartment) (Fig. 5D). This
resulted in a significant difference in MYHC expression
between the populations at day 4 of differentiation as
supported morphologically (data not shown). Furthermore,
the α6ITG expression determined over time during 4 days of
differentiation showed that both cell populations undergo an
increase in α6ITG expression at the time point of differenti-
ation (Fig. 5E). During differentiation, the cells depleted for
α6ITG show a decrease in expression, whereas a sustained
increased gene expression is observed in the α6ITG+cells.
2.4. Blocking of α6ITG inhibits myogenic differentia-
tion of primary muscle stem cells
Primary muscle stem cells were cultured on laminin-coated
cover slips. The α6ITG function was blocked with anti-α6ITG
antibody (GoH3) incubation for 7 days (Sonnenberg et al.,
1988). The antibody binding to the cells was visualized by
immunofluorescence (Fig. 6A). Blocking of α6ITG function
did not interfere with the adhesion of myogenic cells to the
cover slips and myogenic cell division. This was indicated by
the expression of DESMIN both in the presence or absence of
the blocking antibodies (Fig. 6B). The negative staining of
isotype control antibodies indicated antibody specificity
(Fig. 6C). Blocking of the α6ITG function by antibodiesresulted in the inhibition of primary muscle stem cell fusion
into myotubes after exposure to differentiation conditions
for 6 days. Cells lacking GoH3 antibody treatment were able
to form myotubes suggesting an important function of α6ITG
during myogenic differentiation (Fig. 6D).
2.5. RNAi mediated knockdown of α6ITG results in
inhibition of differentiation
The role of α6ITG in muscle stem cell differentiation was
further examined by transient downregulation using siRNA in
proliferating primary muscle stem cells. Transfection with
siRNA targeted against α6ITG expression resulted in sig-
nificant decreased expression of 90% after 24 h (Fig. 7A;
Pb0.01). However, no significance is observed after 48 h post
transfection. Control siRNA (mock) did not result in a
significant downregulation of α6ITG expression. Protein
detection using immunoblotting indicated the downregula-
tion of α6ITG till 72 h compared to mock control (Fig. 7B).
MYOGENIN expression was not detected during the first 96 h
in both groups indicating the proliferative stage of the cells.
After 96 h MYOGENIN expression was upregulated in themock
control group, but remained low in cells with downregulated
α6ITG expression suggesting inhibition of terminal myogenic
differentiation in these cells. Indeed, cells with down-
regulatedα6ITG expression only formed a few thinmyotubes,
even after prolonged time, whereas large myotubes were
observed in the mock control group (Fig. 7D). In addition, the
expression of MYHC as detected with qRT-PCR was signifi-
cantly decreased after α6ITG downregulation (Fig. 7C).
Expression levels of MYF5, MYOD and DESMIN were not
significantly different between the cells with downregulated
α6ITG and mock control cells (data not shown).
3. Discussion
In muscle tissue, satellite cells are heterogeneous as
demonstrated by a distinction in α6ITG expression (Fig. 1).
Laminin is expressed along the muscle fiber within the
extracellular matrix enclosing the muscle fiber, where the
laminin ligands cause α6/β1 integrin heterodimers receptor
binding (Sonnenberg et al., 1990; Hall et al., 1990; Aumailley
et al., 1990; Le Bellego et al., 2002). The localization of
α6ITG integrin expressing satellite cells with laminin-rich
extracellular matrix enclosing the muscle fiber emphasizes
this important ligand binding interaction (Fig. 1H). Previ-
ously, we observed that increased levels of α6ITG expression
in primary muscle stem cells were correlated with a better
myogenic differentiation capacity (Wilschut et al., 2010).
Therefore, we further investigated the role of α6ITG during
myogenesis by selecting and sorting for NCAM expressing
cells with or without α6ITG expression from isolated primary
muscle stem cell culture. NCAM is involved in myoblast fusion
and is expressed by satellite cells that are associated with
myogenic cell commitment (Capkovic et al., 2008; Charlton
et al., 2000). Thereby we could distinguish between
myogenic and non-myogenic cells (Webster et al., 1988;
Capkovic et al., 2008; Mesires and Doumit, 2002; Blanton
et al., 1999; Krauss et al., 2005; Covault and Sanes, 1986).
Three cell populations were obtained; muscle stem cells
positive for α6ITG expression, muscle stem cells negative for
116 K.J. Wilschut et al.α6ITG expression and the non-myogenic cells expressing
neither NCAM nor α6ITG (Fig. 2). Here, the α6ITG positive
myogenic stem cells showed a robust myogenic differentia-
tion capacity as indicated by the expression of MYOGENIN,
DESMIN and MYHC. Interestingly, it was shown that expres-
sion of α6ITG expression is required for myogenic differen-
tiation into myotubes. The α6ITG− cells showed cell
elongation and alignment, but no myoblast fusion (Fig. 3).
The myogenic commitment of the cell populations wasfurther examined by determination of mRNA expression
levels. PAX7 expression was similar between the two
myogenic NCAM+ cell populations after isolation indicating
that they both related to satellite cells. Interestingly, both
α6ITG+ and α6ITG− cells expressed the MRFs MYF5 and
DESMIN, indicating the myogenic commitment of both cell
types. It has been shown that in murine muscle tissue,
myogenic progenitor cells are subdivided in Pax7 expressing
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Figure 4 Cell culture. A. Both NCAM+/ α6ITG+ and NCAM+/
α6ITG− populations showed a bi- and triangular shapedmorphology
with amore flattened appearance for α6ITG expressing cells. Scale
bar is 50 μm. B. Growth curves represent cell amount during
proliferating and differentiating. Cells that express α6ITG exhibit a
lower proliferation rate (●) compared to cells without α6ITG
expression (■. (*pb0.0001). Experimental outcome represents
three biological replicates.
117Alpha 6 integrin is important for myogenic stem cell differentiationexpressing Myf5 (Kuang et al., 2007). The hierarchy is based
on the apical–basal position of the satellite cells towards the
muscle fiber. Satellite cells identified as Pax7+/ Myf5− with
an orientation towards the basal lamina (basal-position)
were demonstrated to express α7β1 integrins. Satellite cells
with an apical orientated position towards the plasma
membrane of the myofiber expressed Myf5 (Kuang et al.,
2007). These Myf5+ cells were indicated as a committed
phenotype due to the loss of contact with the basal lamina
and extracellular environment or niche, which is important
in sustaining stem cell identity. Interestingly, in our
experiments the α6ITG− cells expressed significantly higher
levels of A7ITG and lower levels ofMYF5 compared to α6ITG+Figure 3 Characterization of sorted cell populations. Gene expr
NCAM+/ α6ITG– and NCAM–/ α6ITG– cells relative to unsorted prima
cells after 4 days of induction. MYOGENIN (left, in green) detection o
green) detection represents formation of large multinucleated myo
striated myotubes (arrow head). DNA is visible in blue, scale bar repre
antibodies (GoH3) on cytospins of the sorted cell populations (NCAM
visualizes the expression of α6ITG in the α6ITG+ cells (red). After 2
(arrow; upper right panel), whereas cells lacking α6ITG remained
visualized with DAPI staining (blue). Scale bar is 50 μm. C. The A6ITG
was expressed in NCAM−/ α6ITG− (non-myogenic cells) at significantl
α6ITG− cells. Similar expression levels of B1ITG were detected bet
expressed significantly higher levels of B1ITG. Expression levels o
significantly higher compared to non-myogenic cells. A significantly h
expression of DESMINwas significantly higher in α6ITG− cells. Experim
PCR analysis is run as technical triplicates. Asterisks denote significa
(NCAM+/ α6ITG+, NCAM+/ α6ITG− and NCAM-/ α6ITG-) (ns=no signifcells. This suggests that α6ITG- cells could have a basal
orientated position and not yet directed into the myogenic
program. This indicates that these cells are uncommitted
early muscle precursor cells whereas the α6ITG+ cells could
be the myogenic initiated myogenic progenitor cells. The
non-myogenic cells lacking NCAM expression showed signif-
icant higher levels of A5ITG, which is the receptor for
fibronectin in fibroblasts (Huveneers et al., 2008).
Examination of the proliferation capacity of the two
populations revealed that α6ITG− cells proliferated at a
higher rate than α6ITG+ cells. The α6ITG+ cells stopped
proliferation and formed myotubes by cell fusion, while
α6ITG− cells continued cell proliferation until confluence
was reached (Fig. 4). The high proliferation capacity of
α6ITG− cells is consistent with the involvement of α6 integrin
in the negative regulation of cell growth (Sastry et al., 1996).
The differentiation capacity revealed a diminished myogenic
commitment by cells lacking α6ITG expression compared to
the α6ITG positive cells. Whether the α6ITG negative cells
will become less proliferative and more myogenic when
α6ITG is introduced into these cells for instance by over-
expression, or whether the α6ITG negative cells have already
entered different differentiation pathways is currently
unknown.
Monoclonal antibodies blocked α6ITG expression on
primary muscle stem cells and prohibited myoblast fusion
without affecting proliferation or the expression of muscle-
specific genes. This indicates a direct inhibition of cell fusion
and differentiation. Downregulation of α6ITG mRNA expres-
sion using siRNA oligonucleotides confirmed the role α6ITG in
myogenic differentiation.
Besides muscle satellite cells, several muscle progenitor
cells have been identified so far among which are blood-
vessel associated myo-endothelial cells (Zheng et al., 2007;
Crisan et al., 2008), meso-angioblasts (Minasi et al., 2002)
and muscle-derived stem cells (MDSCs) (Qu-Petersen et al.,
2002). Interestingly, the MDSCs with the highest in vivo
regeneration capacity are the most proliferative in vitro,
similar to the α6ITG− population (Qu-Petersen et al., 2002).
Early preplate (EP) cells, characterized as late myogenic
precursors in vitro (Qu-Petersen et al., 2002), are compara-
ble with the myogenic α6ITG+population. Differences in
α6ITG expression could attribute to the in vitro and in vivo
potentials and α6ITG can therefore be a useful target toession levels were determined by qRT-PCR on NCAM+/ α6ITG+,
ry muscle cells. A. Myogenic differentiation capacity of α6ITG+
n terminal differentiated muscle stem cells. DESMIN (middle, in
tubes (arrow). Formation of MYHC (right, in green) expressing
sents 20 μm. B. Immunofluorescent cell staining with anti-α6ITG
+/ α6ITG+, left upper panels; NCAM+/ α6ITG–, left lower panels)
days of inducing differentiation α6ITG+ cells formed myotubes
aligned showing no cell fusion (lower right panel). Nuclei are
was expressed at significantly higher levels in α6ITG+ cells, A5ITG
y higher levels, while A7ITG was significantly higher expressed in
ween both α6ITG+ and α6ITG– cell but the non-myogenic cells
f PAX7 were detected in α6ITG+ and α6ITG– cells which were
igher MYF5 expression level was detected in α6ITG+ cells, while
ent is performed in three biological replicates, in which the qRT-
nt differences in gene expression between the sorted population










































































































































Fig. 5 Differentiation capacity of NCAM+/ α6ITG+ and NCAM+/ α6ITG- cells. Expression levels during differentiation (diff) are
relative to α6ITG+ cells at day 0 (prol d0). A. PAX7 expression. B. MYF5 expression. C. DESMIN expression. D. MYHC fast type
expression. E. Alpha6ITG expression. Experiment is performed in three biological replicates, in which the qRT-PCR analysis is run as
technical triplicates. Asterisks denote significant differences in gene expression at the specific time point between the sorted
population NCAM+/ α6ITG+ and NCAM+/ α6ITG− (** pb0.01, *** pb0.001).
118 K.J. Wilschut et al.improve muscle regeneration. Studying similarities and
differences between the α6ITG positive and α6ITG negative
cell populations such as characterizing differentiation
potential and in vivo exposure would attribute to a
presumable role for α6ITGs on in vivo engraftment, survival
and self-renewal. Discrimination between behavioral in vivo
cell fate would indicate a preference to re-enter a quiescent
satellite cell position, which could be determined by cell
location towards the muscle fiber and Sprouty expression(Shea et al., 2010), or a more differentiated characteristic
by fusion with myotubes showing a more myogenic regener-
ative potential.
Here, two types of stem cells have been identified in
porcine muscle: those that express α6ITG and those that lack
expression of this integrin type. Cells expressingα6ITGhave an
advantage in the formation of myotubes, possibly by an
improved cell fusion capacity. Whether the cells that lack
α6ITG will eventually start to express this integrin or whether
Fig. 6 Inhibition of α6ITG function using the rat-GoH3 antibodies. Upper row depicts primary muscle stem cells treated with GoH3
antibodies directed against α6ITG. Lower row depicts primary muscle cells without GoH3 antibody treatment. A. Detection of GoH3
antibodies on primary muscle stem cells using Alexa568-labeled secondary antibody against rat-IgGs. B. Visualization of DESMIN
expression indicates adhesion of dividing myoblasts (arrows) on the cover slips. C. Isotype antibody incubations served as negative
control for aspecific antibody binding. Nuclei were stained with DAPI (blue), scale bars represent 20 μm. D. No myotubes were
observed in GoH3 treated primary muscle stem cells after 6 days of differentiation, while cells lacking GoH3 antibody treatment
formed myotubes in culture. Scale bars represent 50 μm. Experimental outcome represents three biological replicates.
Fig. 7 Inhibitory effects of α6ITG downregulation on myogenic differentiation capacity of primary muscle stem cells. A. Messenger
RNA expression levels of α6ITG relative to expression levels directly after transfection (0 h) determined by qRT-PCR. Efficient
downregulation of α6ITG has been obtained by using ITGA6 siRNA. B. Protein levels determined by western blotting confirm silencing
of α6ITG during 96 h post transfection. Myogenic determination was observed in the mock group by MYOGENIN (MYOG) expression.
C. Quantitative RT-PCR confirmed myogenic differentiation of cells transfected with control siRNA by increased levels of MYHC
expression in time. D. Morphological differentiation (myotube formation, arrows) was observed in the mock control group (M), which
was very poor in cells with downregulated α6ITG expression (I). BACT=beta actin. MYHC=myosin heavy chain 2. Scale bars represent
50 μm. (* pb0.01). Experiment is performed in three biological replicates.
119Alpha 6 integrin is important for myogenic stem cell differentiation
120 K.J. Wilschut et al.these cells have a different role in skeletal muscle is not
known. The functions of integrins can be different in the
various stem cell types predisposed by the extracellular
environment and developmental progression. It has, for
instance, been established that α6/β1 integrins are markers
of neural stem cells, and that expression of these integrins
decreases in differentiated neural cell types (Hall et al., 1990),
which is opposite to our finding. However, skeletalmuscle cells
are a different type of cells that require fusion of progenitor
cells during maturation. We propose that α6ITG is particularly
important to establish fusion of the muscle progenitor cells
important for differentiation of skeletal muscle.
In this study, it is proposed that α6ITG could serve as a
biomarker to select for highly myogenic stem cells that may be
used in experimental stem cell therapy. It should however be
investigated whether cells expressing α6ITG lead to better
engraftment than α6ITG negative cells, since successful
engraftment encompasses more than in vitro differentiation
efficiency.4. Materials and methods
4.1. Isolation of porcine primary muscle stem cells
Porcine primary muscle stem cells were isolated from
semitendinosus muscle of euthanized (intracardial injection
of 0.15 ml/kg T61) piglets (hybrid York boars; 3 months of
age). The dissected muscle parts were minced with scalpels
after removal of adipose and connective tissues. Minced
muscle tissue (50 g in total) was centrifuged (5 min, 2000 g) in
phosphate-buffered saline (PBS, Braun, Melsungen, Germany)
containing 1% HEPES and a cocktail of anti-bacterial agents
(50 μg/ml gentamycin, 1% antibiotic-antimycotic mix and
250 ng/ml fungizone (all from Sigma ST Louis, MO), referred
to as PBS+-H. Muscle tissue parts were digested in 100 ml
preheated 1 mg/ml protease solution (from Streptomyces
griseus, Sigma, ST Louis, MO) in PBS+-H for 60 minutes at 37 °C
under repeated shaking as described previously (Doumit and
Merkel, 1992; Gharaibeh et al., 2008). To further homogenize
the tissue, trituration with 5 ml pipettes was performed.
Undigested larger muscle parts were collected by modest
centrifugation (5 min at 200 g) and stored on ice. Supernatant,
containing single cells, was washed twice (10 min at 2000 g) in
growthmedium (GM) [Dulbecco's ModifiedEagle's Medium-high
glucose (DMEM-HG, Invitrogen, Carlsbad, CA), 20% fetal bovine
serum (FBS, Invitrogen) and 50 μg/ml gentamycin]. The cells
were filtered with cell strainers (pore size 70 μm, BD Falcon,
Erembodegem, Belgium) and subsequently pelleted (10 min at
2000 g). Cell pellets were stored on ice. Further dissociation of
cells from the remaining undigested muscle parts was
performed by a 1 hour incubation with 0.15% w/v collagenase
XI (Sigma) in DMEM-HG with 1% HEPES and 5% FBS. During
incubation tissue solutionwas repeatedly trituratedwith 10 ml
pipettes. Finally, the fully digested tissue was filtered (70 μm
cell strainer), washed in GM and pelleted (10 min at 2000 g).
To shock the erythrocytes both cell pellets were pooled in
20 ml cold hypotonic buffer (0.2 M NH4Cl, 13 mM KHCO3, pH
7.4) for 10 min on ice and centrifuged in cold PBS+-H (5 min at
1000 g). Cells were taken up in GM, filtered through a 40 μm
cell strainer (BD Falcon) to remove small tissue debris and
subsequently collected by pelleting (5 min at 700 g). Cellswere pre-plated in GM in addition of antibiotic–antimycotic
mix and fungizone in uncoated T175 flasks (Corning Life
Sciences, Amsterdam, The Netherlands) for the exclusion of
fast-adhering fibroblasts during 1 h (37 °C, 5% CO2). Cells that
had not adhered were collected and stored in liquid nitrogen
until further use (Qu et al., 1998). All steps were performed at
room temperature (RT), unless otherwise mentioned.
4.2. Muscle stem cell proliferation and
differentiation
For cell expansion primary muscle stem cells were cultured
in 1 mg/ml Matrigel (Matrigel™ Basement Membrane Matrix;
mouse tumor; phenol-red free, BD Bioscience, Bedford, MA)
coated flasks (Sigma) in GM containing 5 ng/ml human basic
fibroblast growth factor (bFGF; Sigma). Differentiation of
the muscle stem cells was performed in differentiation
medium [DM; DMEM-HG, 2% horse serum (HS, Invitrogen) with
50 μg/ml gentamycin] on laminin-coated (1 μg/ml) Lumox
dishes (Ø 35 mm; Greiner Bio-One, Frickenhausen, Germany)
or on laminin-coated 6-wells plates (Greiner Bio-One).
4.3. FACS sorting
Indirect cell staining with primary mouse antibodies against
NCAM (5.1H11; 1:200 dilution; Developmental Studies
Hybridoma Bank, Iowa City, IA) and rat antibodies against
α6ITG (GoH3; 2.5 μg/ml; BD) was used to select for specific
cell populations by flow cytometry using a VantageTM SE
flowcytometer (BD). Fluorescent conjugated secondary
goat-anti mouse-PE and goat-anti rat-FITC antibodies were
used to localize the primary antibodies. Isotype control
antibodies (rat-IgG2 and mouse-IgG1; both 1:10 dilution;
DakoCytomation, Glostrup, Denmark) were used to gate the
fluorescence threshold for antibody specificity based on the
visualization of nonspecific binding by the primary anti-
bodies. Data were analyzed using FlowJo software (Oregon
corporations, Ashland, OR).
4.4. Indirect immunofluorescence
After sorting by flow cytometry, cell populations were spun
onto glass cover slides for 5 min at 800 rpm in 0.5% BSA in PBS
using the Shandon Cytospin 4 (Thermo Scientific, Breda, The
Netherlands). The cover slideswere dried overnight and stored
at −80 °C until further use. Furthermore, primarymuscle stem
cells were cultured for 6 days in GM on 1 μg/cm2 laminin-
coated (murine sarcoma; Sigma) glass cover slips and on
laminin-coated Lumox dishes for 4 days in DM. Cells were fixed
in cold methanol (2 min at −20 °C) for α6ITG staining. To stain
DESMIN, MYOGENIN and Myosin heavy chain (MYHC) cells were
fixed in 4% paraformaldehyde (PFA; Electron Microscopy
Science,Hatfield, PA) for 15 min, followedby permeabilization
in 0.5% Triton X-100 for 10 min. Snap-frozen muscle tissue was
cryosectioned (5 μm), fixed in 4% PFA (15 min) and incubated
for 30 min in blocking buffer [2% normal goat serum (DakoCy-
tomation), 1% Bovine Serum Albumin (BSA; Roth, Karlsruhe,
Germany), 0.1% fish gelatin (Sigma), 0.1% Triton X-100, 0.05%
Tween-20 in PBS] to avoid aspecific antibody binding.
Subsequently, cells were incubated with primary antibodies
α6ITG (rat, clone GoH3; 10 μg/ml; BD), DESMIN (mouse, clone
121Alpha 6 integrin is important for myogenic stem cell differentiationD33; 10 μg/ml; DakoCytomation), MYOGENIN (mouse, clone
F5D; 10 μg/ml; BD),MYHC (mouse, cloneMY-32; 1:400; Sigma),
PAX7 (mouse, clone PAX7; 10 μg/ml; R&D systems, MN) and
Laminin (rabbit; 1:25; Sigma) in blocking buffer for 1 h. After
washing in PBS with 0.05% Tween-20 (PBST; 3 times; 5 min)
slides were incubated with Alexa488-labeled or Alexa568-
labeled goat anti-mouse/ anti-rat/ anti-rabbit IgG (1:200;
Invitrogen) for 45 min. Slideswerewashed in PBST, followed by
counterstaining with DAPI (Invitrogen) to visualize the nuclei.
Slides were dehydrated in an increasing alcohol series (70%,
90%and 100%; 3 min each), air-driedbeforebeing overlaidwith
FluorSave (Calbiochem, Darmstadt, Germany) and covered
withglass.All antibody solutionswerecentrifuged for 10 min at
4 °C at full speed prior to use. All steps were performed at RT.
Visualization of fluorescently labeled secondary antibodieswas
performed on a Leica DMRE fluorescence microscope.4.5. Inhibition of α6ITG expression
On laminin expanded primary muscle stem cells were seeded
at a density of 3000 cells/cm2 into a laminin coated 12-wells
plate. Blocking of α6ITG expression on primary muscle stem
cells was performed in presence of the blocking antibody
GoH3 (GoH3; 2.5 μg/ml; BD). After 8 days of cell culturing in
GM differentiation was induced during 6 days in DM.
Proliferation and differentiation medium was refreshed
every third day with addition of GoH3 antibody.
Expression of α6ITG in primary muscle stem cells was
downregulated by RNAi mediated knockdown. Cells were
transfected with α6ITG siRNA duplex oligoribonuleotides
(5′-GAAACGUGCUGUUCCAUAA-3′) using electroporation (1
time at 160 V, 70 ms pulse length; ECM 830 Electroporation
System, Harvard Apparatus, Kent, UK). Universal controlTable 1 Overview of primers used for quantitative RT-PCR.
Gene Primer sequence 5′→3′ Amplicon
ITGA5 F: GCCTGCAAAGATCTGTCCTC 215 bp
R: AGAGTTCCCCTTGGAGTGGT
ITGA6 F: AAACGAGAAATTGCTGAAAGAC 365 bp
R: CACTAGAATGATCCACCAAGG
ITGA7 F: CAGAGCTGGCTGCTGGTG 132 bp
R: CTGGTCGATGTCCACTCTGT
ITGB1 F: ATGAGGAGGATTACTTCAGACTTC 304 bp
R: GCAGCCGTGTCACATTCC
PAX7 F: GGTGGGGTTTTCATCAATGG 155 bp
R: GTCTCTTGGTAGCGGCAGAG
MYF5 F: TGCCATCCGCTACATTGAGAG 160 bp
R: GTTCTTTCGGGACCAGACAGG
DESMIN F: CCGAGATCTACGAGGAGGAG 162 bp
R: TCTCGGCTTCTTCTTTCAGC
MYHC-2 F: CCGTCTGGATGAGGCTGAG 179 bp
R: CCGTCTGGTAGGTGAGTTCC
PGK1 F: AGATAACGAACAACCAGAGG 126 bp
R: TGTCAGGCATAGGGATACC
UBQ F: TTCGTGAAGACCTTGACTG 186 bp
R: GGACTCCTTCTGGATGTTG
GAPDH F: TCGGAGTGAACGGATTTG 219 bp
R: CCTGGAAGATGGTGATGGsiRNA duplex oligoribonuleotides were used as a nonspecific
control (mock) (all purchased from Eurogentec, Maastricht,
The Netherlands). Cells were transfected with 500 pmol
siRNA per 1×105 cells and seeded onto Matrigel-coated
plates in a density of 5000 cells/cm2 in GM. After 48 h
myogenic differentiation was induced by medium replace-
ment for DM. Cells were collected for RNA and protein
isolation at 0 h to 120 h of culturing.4.6. Quantification of gene expression
RNA isolation using a RNeasy Mini Kit (Qiagen, Valencia, CA)
was either performed from directly sorted cell populations or
from cell cultures which were first trypsinized (0.25%
Trypsin-EDTA, Invitrogen), pelleted by centrifugation
(5 min at 300 g) and stored at −80 °C before RNA isolation.
Additionally, a second DNase treatment was performed on
RNA samples by incubation with 2 μl DNase (Qiagen) for
25 min at 37 °C, followed by inactivation for 10 min at 70 °C.
The cDNA was generated using Superscript™ III First-strand
Synthesis System (Invitrogen) and quantitative real-time RT-
PCR (qRT-PCR) performed on cDNA (1 μl) using an iCycler
with iQ™ SYBR® Green supermix (both from BIO-RAD,
Hercules, CA). A 12.5 pmol primer concentration per 25 μl
reaction amplified cDNA after a denaturation step of 3 min at
95 °C in a 40 cycle protocol [30 s at 95 °C, 20 s 51–63 °C
(Table 1 Wilschut et al., 2010; Wilschut et al., 2008; Kuijk
et al., 2007), 30 s at 72 °C and subsequently 77 repeats of
15 s with a 0.5 °C increase in temperature after every repeat
starting at 60 °C]. Primer specificity was confirmed by product
sequencing. For relative gene expression quantification sam-
ples were normalized against mRNA levels of reference genes
(GAPDH,UBQ and PGK1) usingGeNorm software (Primer Designsize Ta (°C) GenBank accession no.
58 XM_001925252 (Wilschut et al., 2010)
54 NM_001109981 (Wilschut et al., 2010)
60 XM_001916598 (Wilschut et al., 2010)
53 NM_213968
55 AY653213 (Wilschut et al., 2008)
55 Y17154 (Wilschut et al., 2010)
55 AF363284 (Wilschut et al., 2010)
60 NM_214136 (Wilschut et al., 2008)
56.4 AY677198 (Kuijk et al., 2007)
51 M18159 (Kuijk et al., 2007)
51 AF017079 (Kuijk et al., 2007)
122 K.J. Wilschut et al.Ltd., Southampton, UK) (Vandesompele et al., 2002). Gene
expression levels of siRNA-transfected cells and mock-trans-
fected cells were normalized against PGK1 expression levels
and plotted relatively to expression levels determined directly
after transfection (0 h) (Fig. 7). Results were analyzed using
GraphPad prism in a two-way ANOVA with a Bonferroni post-
test.4.7. Immunoblotting
Cells were washedwith cold PBS and lysed in buffer containing
140 mM NaCl, 50 mM Tris–HCL pH7.5, 1 mM EDTA, 0.1% Triton
X-100, 10% glycerol and protease inhibitor cocktail 1
tablet/50 ml lysis buffer (Roche Applied Sciences, Almere,
The Netherlands). Proteinmeasurement was performedwith a
DC protein assay (Bio-Rad, Veenendaal, The Netherlands).
Equal amounts (3.5 μg) of reduced (5 min at 95 °C) protein
lysate was separated onto 12% Tris–HCl PAGE gels and blotted
to Trans-Blot nitrocellulose transfer membranes (Bio-Rad).
Membranes were blocked in 5% Blotting Grade Blocker non-fat
drymilk in 1x PBS-0.1% Tween X-100 for 1 h and incubatedwith
primary antibodies against ITGA6 (rabbit polyclonal, 1:1000;
Cell Signaling Technology, Danvers, MA), MYOGENIN (F5D,
mouse, 2 μg/ml, BD) and BACT (rabbit polyclonal; 1:1000; Cell
Signaling Technology). Secondary incubation for 1 h with
horseradish peroxidase-conjugated anti-mouse/rabbit IgG
(1:5000; Santa Cruz Biotechnology, Santa Cruz, CA) was
followed by SuperSignal West Dura Extended Duration Sub-
strate (Pierce, ThermoScientific, Erembodegem, Belgium)
after which the blots were exposed to autoradiography film
(Kodak, Rochester, NY).Author disclosure statement
No potential conflicts of interest.Acknowledgments
This work was supported by a SenterNovem grant from the
Ministery of Economic Affairs. The NCAM antibody (5.1H11)
developed by H.M. Blau and F.S. Walsh was obtained from
the Developmental Studies Hybridoma Bank developed under
the auspices of the NICHD and maintained by The University
of Iowa, Department of Biological Sciences, Iowa City, IA
52242. KW was responsible for the design, experimental
procedures and was the primary author for the manuscript.
HT largely contributed to the RNAi silencing procedures and
GA supported the flow cytometric procedures. HH supervised
the design and analysis. BR supervised the design, analysis
and writing.References
Alapat, D.V., et al., 2009. Fiber-types of sarcomeric proteins
expressed in cultured myogenic cells are modulated by the
dose of myogenin activity. Cell. Signal. 21 (1), 128–135.
Aumailley, M., Timpl, R., Sonnenberg, A., 1990. Antibody to integrin
alpha 6 subunit specifically inhibits cell-binding to laminin
fragment 8. Exp. Cell Res. 188 (1), 55–60.Bajanca, F., et al., 2004. Integrins in the mouse myotome:
developmental changes and differences between the epaxial
and hypaxial lineage. Dev. Dyn. 231 (2), 402–415.
Bajanca, F., et al., 2006. Integrin alpha6beta1-laminin interactions
regulate early myotome formation in the mouse embryo.
Development 133 (9), 1635–1644.
Bao, Z.Z., et al., 1993. Alpha 7 beta 1 integrin is a component of the
myotendinous junction on skeletal muscle. J. Cell Sci. 106 (Pt 2),
579–589.
Blanton Jr., J.R., et al., 1999. Isolation of two populations of
myoblasts from porcine skeletal muscle. Muscle Nerve 22 (1),
43–50.
Buckingham, M., et al., 2003. The formation of skeletal muscle: from
somite to limb. J. Anat. 202 (1), 59–68.
Capkovic, K.L., et al., 2008. Neural cell adhesion molecule (NCAM)
marks adult myogenic cells committed to differentiation. Exp.
Cell Res. 314 (7), 1553–1565.
Cerletti, M., et al., 2008. Highly efficient, functional engraftment of
skeletal muscle stem cells in dystrophic muscles. Cell 134 (1),
37–47.
Charlton, C.A., Mohler, W.A., Blau, H.M., 2000. Neural cell adhesion
molecule (NCAM) and myoblast fusion. Dev. Biol. 221 (1),
112–119.
Covault, J., Sanes, J.R., 1986. Distribution of N-CAM in synaptic and
extrasynaptic portions of developing and adult skeletal muscle.
J. Cell Biol. 102 (3), 716–730.
Crisan, M., et al., 2008. Purification and long-term culture of
multipotent progenitor cells affiliated with the walls of human
blood vessels: myoendothelial cells and pericytes. Methods Cell
Biol. 86, 295–309.
Danen, E.H., Sonnenberg, A., 2003. Integrins in regulation of tissue
development and function. J. Pathol. 201 (4), 632–641.
Doumit, M.E., Merkel, R.A., 1992. Conditions for isolation and culture
of porcine myogenic satellite cells. Tissue Cell 24 (2), 253–262.
Gharaibeh, B., et al., 2008. Isolation of a slowly adhering cell
fraction containing stem cells frommurine skeletal muscle by the
preplate technique. Nat. Protoc. 3 (9), 1501–1509.
Gullberg, D., et al., 1998. Integrins during muscle development and
in muscular dystrophies. Front. Biosci. 3, D1039–D1050.
Hall, D.E., et al., 1990. The alpha 1/beta 1 and alpha 6/beta 1
integrin heterodimers mediate cell attachment to distinct sites
on laminin. J. Cell Biol. 110 (6), 2175–2184.
Hayashi, Y.K., et al., 1998. Mutations in the integrin alpha7 gene
cause congenital myopathy. Nat. Genet. 19 (1), 94–97.
Hemler, M.E., 1999. Dystroglycan versatility. Cell 97 (5), 543–546.
Hierck, B.P., et al., 1993. Variants of the alpha 6 beta 1 laminin
receptor in early murine development: distribution, molecular
cloning and chromosomal localization of the mouse integrin
alpha 6 subunit. Cell Adhes. Commun. 1 (1), 33–53.
Huveneers, S., et al., 2008. Binding of soluble fibronectin to integrin
alpha5 beta1 — link to focal adhesion redistribution and
contractile shape. J. Cell Sci. 121 (Pt 15), 2452–2462.
Hynes, R.O., 2002. Integrins: bidirectional, allosteric signaling
machines. Cell 110 (6), 673–687.
Krauss, R.S., et al., 2005. Close encounters: regulation of vertebrate
skeletal myogenesis by cell–cell contact. J. Cell Sci. 118 (Pt 11),
2355–2362.
Kuang, S., et al., 2007. Asymmetric self-renewal and commitment of
satellite stem cells in muscle. Cell 129 (5), 999–1010.
Kuijk, E.W., et al., 2007. Validation of reference genes for
quantitative RT-PCR studies in porcine oocytes and preimplan-
tation embryos. BMC Dev. Biol. 7, 58.
Le Bellego, F., et al., 2002. Laminin-alpha6beta1 integrin interac-
tion enhances survival and proliferation and modulates steroido-
genesis of ovine granulosa cells. J. Endocrinol. 172 (1), 45–59.
McKinnell, I.W., et al., 2008. Pax7 activates myogenic genes by
recruitment of a histone methyltransferase complex. Nat. Cell
Biol. 10 (1), 77–84.
123Alpha 6 integrin is important for myogenic stem cell differentiationMenko, A.S., Boettiger, D., 1987. Occupation of the extracellular
matrix receptor, integrin, is a control point for myogenic
differentiation. Cell 51 (1), 51–57.
Mesires, N.T., Doumit, M.E., 2002. Satellite cell proliferation and
differentiation during postnatal growth of porcine skeletal
muscle. Am. J. Physiol. Cell Physiol. 282 (4), C899–C906.
Minasi, M.G., et al., 2002. The meso-angioblast: a multipotent, self-
renewing cell that originates fromthedorsal aorta anddifferentiates
into most mesodermal tissues. Development 129 (11), 2773–2783.
Montarras, D., et al., 2005. Direct isolation of satellite cells for
skeletal muscle regeneration. Science 309 (5743), 2064–2067.
Oustanina, S., Hause, G., Braun, T., 2004. Pax7 directs postnatal
renewal and propagation of myogenic satellite cells but not their
specification. EMBO J. 23 (16), 3430–3439.
Pownall, M.E., Gustafsson, M.K., Emerson Jr., C.P., 2002. Myogenic
regulatory factors and the specification of muscle progenitors in
vertebrate embryos. Annu. Rev. Cell Dev. Biol. 18, 747–783.
Qu, Z., et al., 1998. Development of approaches to improve cell survival
in myoblast transfer therapy. J. Cell Biol. 142 (5), 1257–1267.
Qu-Petersen, Z., et al., 2002. Identification of a novel population
of muscle stem cells in mice: potential for muscle regeneration.
J. Cell Biol. 157 (5), 851–864.
Relaix, F., et al., 2005. A Pax3/Pax7-dependent population of
skeletal muscle progenitor cells. Nature 435 (7044), 948–953.
Rudnicki, M.A., et al., 1993. MyoD or Myf-5 is required for the
formation of skeletal muscle. Cell 75 (7), 1351–1359.
Sastry, S.K., et al., 1996. Integrin alpha subunit ratios, cytoplasmic
domains, and growth factor synergy regulate muscle prolifera-
tion and differentiation. J. Cell Biol. 133 (1), 169–184.
Seale, P., et al., 2000. Pax7 is required for the specification of
myogenic satellite cells. Cell 102 (6), 777–786.
Shea, K.L., et al., 2010. Sprouty1 regulates reversible quiescence of
a self-renewing adult muscle stem cell pool during regeneration.
Cell Stem Cell 6 (2), 117–129.
Sherwood, R.I., et al., 2004. Isolation of adult mouse myogenic
progenitors: functional heterogeneity of cells within and
engrafting skeletal muscle. Cell 119 (4), 543–554.Sonnenberg, A., Modderman, P.W., Hogervorst, F., 1988. Laminin
receptor on platelets is the integrin VLA-6. Nature 336 (6198),
487–489.
Sonnenberg, A., et al., 1990. Integrin recognition of different cell-
binding fragments of laminin (P1, E3, E8) and evidence that alpha
6 beta 1 but not alpha 6 beta 4 functions as a major receptor for
fragment E8. J. Cell Biol. 110 (6), 2145–2155.
Tajbakhsh, S., 2005. Skeletal muscle stem and progenitor cells:
reconciling genetics and lineage. Exp. Cell Res. 306 (2),
364–372.
Tamaki, T., et al., 2002. Identification of myogenic-endothelial
progenitor cells in the interstitial spaces of skeletal muscle.
J. Cell Biol. 157 (4), 571–577.
van der Flier, A., Sonnenberg, A., 2001. Function and interactions of
integrins. Cell Tissue Res. 305 (3), 285–298.
Vandesompele, J., et al., 2002. Accurate normalization of real-
time quantitative RT-PCR data by geometric averaging of
multiple internal control genes. Genome Biol. 3 (7)
p. RESEARCH0034.
von der Mark, H., et al., 1991. Skeletal myoblasts utilize a novel
beta 1-series integrin and not alpha 6 beta 1 for binding to the E8
and T8 fragments of laminin. J. Biol. Chem. 266 (35),
23593–23601.
Webster, C., et al., 1988. Isolation of human myoblasts with the
fluorescence-activated cell sorter. Exp. Cell Res. 174 (1),
252–265.
Wilschut, K.J., et al., 2008. Isolation and characterization of porcine
adult muscle-derived progenitor cells. J. Cell. Biochem. 105 (5),
1228–1239.
Wilschut, K.J., Haagsman, H.P., Roelen, B.A., 2010. Extracellular
matrix components direct porcine muscle stem cell behavior. Exp.
Cell Res. 316 (3), 341–352.
Zammit, P.S., et al., 2006. Pax7 and myogenic progression in
skeletal muscle satellite cells. J. Cell Sci. 119 (Pt 9), 1824–1832.
Zheng, B., et al., 2007. Prospective identification of myogenic
endothelial cells in human skeletal muscle. Nat. Biotechnol. 25
(9), 1025–1034.
